Some AMPs specifically target tumor or cancer cells because transformed cells generally incorporate phosphatidylserine (PS, 3–9% of the total amount of phospholipids) in the outer leaflet of the plasma membrane (Figure 2) [76–78]. The gene discussed is ADSL; the disease is neoplasm.